|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.2944 USD | -4.69% |
|
-13.11% | -77.35% |
| 08-11 | HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy | MT |
| 08-10 | Heron Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 55.89M 50.06M 46.19M 41.8M 78.15M 5.32B 79.42M 551M 220M 2.79B 210M 205M 8.82B | P/E 2026 * |
-2.26x | P/E 2027 * | -2.68x |
|---|---|---|---|---|---|
| Enterprise Value | 55.89M 50.06M 46.19M 41.8M 78.15M 5.32B 79.42M 551M 220M 2.79B 210M 205M 8.82B | EV / Sales 2026 * |
0.38x | EV / Sales 2027 * | 0.38x |
| Free-Float |
99.01% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HRTX | Delayed | |
CBOE
| HRTX | Real-time | |
|
Tradegate
| AXD2 | Real-time | |
|
Boerse Muenchen
| AXD2 | Real-time | |
|
Deutsche Boerse AG
| AXD2 | Delayed | |
|
Börse Stuttgart
| AXD2 | Delayed | |
|
Berne S.E.
| AXD2 | End-of-day quote |
Last Transcript: Heron Therapeutics, Inc.
| 1 day | -4.69% | ||
| 1 week | -13.11% | ||
| Current month | -6.09% | ||
| 1 month | +0.89% | ||
| 3 months | -39.41% | ||
| 6 months | -75.67% | ||
| Current year | -77.35% |
| 1 week | 0.28 |  | 0.32 |
| 1 month | 0.28 | | 0.43 |
| Current year | 0.26 | | 1.58 |
| 1 year | 0.26 | | 1.58 |
| 3 years | 0.26 | | 3.93 |
| 5 years | 0.26 | | 12.79 |
| 10 years | 0.26 | | 42.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 60 | 2023-04-02 |
Ira Duarte
DFI | Director of Finance/CFO | 57 | 2023-06-15 |
Mark Hensley
COO | Chief Operating Officer | 43 | 2025-04-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Johnson
BRD | Director/Board Member | 64 | 2014-01-12 |
Christian Waage
BRD | Director/Board Member | 59 | 2016-06-21 |
| Director/Board Member | 51 | 2021-09-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/6/26 | Exercice | Chief Operating Officer | 71,388 | 0.0377% | ||
| 7/31/26 | Exercice | Chief Executive Officer | 69,578 | 0.0368% | ||
| 7/31/26 | Exercice | Chief Operating Officer | 23,538 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.69% | -13.11% | -75.26% | -53.03% | 58.65M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.26% | +12.91% | +82.98% | 55.53B | |
| +1.75% | +2.76% | +12.38% | +103.69% | 53.03B | |
| -1.43% | -0.57% | +26.10% | +52.86% | 45.99B | |
| -0.48% | -3.86% | +17.27% | +117.99% | 42.45B | |
| +0.82% | -2.06% | +227.09% | +922.41% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +44.58% | +102.84% | +88.74% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.78% | +2.56% | +39.42% | +141.62% | 39.26B | |
| Weighted average by Cap. | -0.08% | +3.13% | +49.24% | +160.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 148M 133M 123M 111M 207M 14.12B 211M 1.46B 583M 7.39B 556M 545M 23.4B | 146M 131M 121M 109M 204M 13.89B 207M 1.44B 574M 7.27B 548M 536M 23.03B |
| Net income | -25M -22.39M -20.66M -18.69M -34.96M -2.38B -35.52M -246M -98.32M -1.25B -93.82M -91.82M -3.95B | -21M -18.81M -17.35M -15.7M -29.36M -2B -29.84M -207M -82.59M -1.05B -78.81M -77.13M -3.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | US$0.2944 | -4.69% | 847,555 |
| 26-10-28 | US$0.3089 | +2.45% | 701,728 |
| 26-10-27 | US$0.3015 | +0.27% | 1,140,080 |
| 26-10-26 | US$0.3007 | -0.69% | 1,056,082 |
| 26-10-23 | US$0.3028 | +2.23% | 1,308,952 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HRTX Stock
Select your edition
All financial news and data tailored to specific country editions
